 "Covid-19: Pakistan approves China's Sinovac vaccine for emergency use")
Amid te ongoing third wave of the Covid-19 pandemic, the Drug Regulatory Authority of Pakistan (DRAP) has approved China's Sinovac vaccine against the virus for emergency use, the National Institute of Health in Islamabad announced.
According to a statement released by DRAP, the CoronaVac vaccine developed by Chinese pharmaceutical company Sinovac has been given emergency use authorization for people aged 18 and above, Xinhua news agency reported.
The statement said the authorization will be reviewed every quarter keeping in view data regarding safety, efficacy and quality of the vaccine.
It is the third Chinese Covid-19 vaccine to be approved by the country after Sinopharm and CanSino vaccines.
Pakistan kicked off its vaccination drive in early February upon receiving vaccine donation from China.
So far, Pakistan has reported 710,829 confirmed cases with 15,229 deaths.
--IANS
ksk/
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app